Where the initial authorisation was granted after the Director General of the Agence nationale de sécurité du médicament et des produits de santé or the Prefect had been informed in accordance with the procedure laid down in Articles R. 5142-6 or R. 5142-7, they will be informed of the amendment within fifteen days.